Investigating the immunizing effect of the rubella epidemic in Japan, 2012-14  by Nishiura, Hiroshi et al.
International Journal of Infectious Diseases 38 (2015) 16–18Short communications
Investigating the immunizing effect of the rubella epidemic
in Japan, 2012-14
Hiroshi Nishiura a,b,*, Ryo Kinoshita a,b, Yuichiro Miyamatsu a,b, Kenji Mizumoto c
aGraduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 1130033, Japan
bCREST, Japan Science and Technology Agency, Honcho 4-1-8, Kawaguchi, Saitama, 332-0012 Japan
cGraduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 1538902, Japan
A R T I C L E I N F O
Article history:
Received 5 June 2015
Received in revised form 5 July 2015
Accepted 7 July 2015
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark
Keywords:
rubella
epidemic
seroepidemiologic studies
vaccination
Japan
A B S T R A C T
Objectives: A rubella epidemic occurred in Japan from 2012-14, involving more than 15,000 cases. The
present study aimed to estimate the immunizing effect of the epidemic, analyzing seroepidemiological
data that were collected over time and age.
Methods: Annual nationwide cross-sectional surveys were conducted from July to September, collecting
serum from at least 5,400 individuals. The proportions seropositive were estimated before (2012), during
(2013) and after (2014) the epidemic.
Results: While the cases were mainly seen among men aged from 30-49 years, no signiﬁcant increase
was observed in the proportion seropositive in the corresponding age group. Even after the epidemic,
age-standardized proportion seropositive of the total population remained 79.3% (95% conﬁdence
interval (CI): 75.2, 83.4) and that among males was as small as 76.7% (95% CI: 73.8, 79.6).
Conclusions: Susceptible pockets remain in Japan, exposing the country to risk of additional rubella
epidemics.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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From 2012-14, Japan experienced a large-scale rubella epi-
demic, involving more than 15,000 cases along with 43 notiﬁed
congenital rubella syndrome (CRS) cases.1 A peculiar feature of the
epidemic has been seen in the age-distribution of cases: the
highest incidence was observed among those aged from 30-39
years, followed by those aged from 40-49 years.2–5 As another
remarkable observation, nearly 80% of cases were males.2 These
features are associated with routine immunization schedules in
the past. From 1977-94, only females at junior high school were
targeted for rubella vaccination aiming to prevent CRS at an
individual level, but subsequently, the country shifted the policy to
target both males and females aged 12-90 months from 1995.
A certain fraction of adult males aged from 20-49 years in the
present day has remained susceptible.* Corresponding author. Graduate School of Medicine, The University of Tokyo,
7-3-1 Hongo, Bunkyo-ku, Tokyo 1130033, Japan. Tel.: +81 3 5841 3688;
fax: +81 3 5841 3637.
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1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).As a consequence of the epidemic with immunizing effect, it is
expected that some susceptible hosts have acquired immunity for
two different reasons, i.e., natural infection and vaccination.
Moreover, the immunity level among those who were immune
before the epidemic is likely to have been elevated, due to a booster
effect by exposure to infected individuals or by revaccination. The
present study is aimed to estimate the immunizing effect of the
epidemic, analyzing seroepidemiological data that were collected
over time and age, thereby to assess if the susceptible fraction has
been substantially lowered in Japan.
2. Materials and Methods
The seroepidemiological data were obtained from the National
Epidemiological Surveillance of Vaccine-Preventable Diseases
(NESVPD) after being approved by the Institutional Review Board.6
Every year from July to September, the cross-sectional serological
survey is conducted and its area is non-randomly selected. More
than 5,400 participants ranging from all age groups were manually
recruited at regional levels, mostly among those who visited a
prefectural medical facility or public health center for some other
purpose. The timing of surveys from 2012-14 corresponds tociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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against rubella has been assessed by hemagglutination inhibition
(HI) assay. From 2012-14, serological testing covered a total of
2,225, 2,586 and 2,882 males and 2,869, 2,938 and 2,861 females,
respectively.
From combinations of the three years of cross-sectional
serological surveys, distributions of HI titer by sex were obtained
in all ages. Gender-speciﬁc analysis was conducted because the
epidemic from 2012-14 was clustered among adult males and past
vaccination histories greatly differed by gender. Since the surveyFigure 1. Proportion seropositive against rubella before, during and after the epidemic
Panels A, C and E. Age-dependent proportion seropositive against rubella before (2012), d
is shown. Horizontal grey line indicates the herd immunity threshold of 83.6%, as calcul
expected to be prevented. The basic reproduction number of rubella is assumed at 6.1
2012 and 2014 as well as 2013 and 2014. The horizontal solid line represents 0% differen
from the binomial distribution.does not follow a cohort design, the ratio of the titer at an
individual level cannot be measured, and thus, seropositive was
deﬁned as those with HI titer 32 times or greater (32), following
the convention in Japan (corresponding to enzyme-linked immu-
nosorbent assay at 7.3 IU/ml or greater). Seroprevalence data were
compared against herd immunity level, as calculated from 1-1/R0,
where R0 is the basic reproduction number (i.e. the average
number of secondary cases generated by a single primary case in a
fully susceptible population) assumed at 6.1.7 Subsequently, the
seroprevalence in two years p1 and p2 was determined, and in Japan, 2012-14
uring (2013) and after (2014) the epidemic in Japan. The sample proportion positive
ated from 1-1/(basic reproduction number), implies from above major epidemic is
.7 Panels B, D and F. Age-speciﬁc difference in proportions seropositive between
ce. Whiskers extend to the upper and lower 95% conﬁdence intervals as calculated
H. Nishiura et al. / International Journal of Infectious Diseases 38 (2015) 16–1818the elevation of the proportion seropositive was assessed by the
difference p2-p1. The 95% conﬁdence intervals (CI) were calculated
as practiced elsewhere.8
3. Results
Figures 1A, 1C and 1E compare the proportion seropositive over
time and age for the total population and also by gender. From
visual assessment, three-year data were almost synchronized
through age. Comparing seroprevalence data against herd immu-
nity level, the sample proportions positive among males were
frequently below the threshold, especially among 10s-40s. An
evident fraction below the threshold was seen even after the
epidemic (2014) among males aged from 35-49 years. Calculating
the age-standardized proportion seropositive in 2014, the immune
fraction of the total population remained 79.3% (95% conﬁdence
interval (CI): 75.2, 83.4). The estimate of seropositive males
appeared to be 76.7% (95% CI: 73.8, 79.6), which was well below
the herd immunity threshold. The estimate of females was 79.3%
(95% CI: 75.2, 83.4).
Figures 1B, 1D and 1F show the change in the estimated
proportions acquiring immunity towards rubella by sex, compar-
ing 2014 data against before (2012) and during (2013) the
epidemic. While an increase in the sample difference was seen
among males aged from 30-39 years, the increase was not
statistically signiﬁcant. Moreover, no signiﬁcant increase was
observed across all age groups for both males and females. There
were even signiﬁcant decreases in seroprevalence when compar-
ing 2012 and 2014 among 40-49 years old for both genders,
presumably caused by decay in antibody titer or spatial sampling
bias.
4. Discussion
The present study assessed the proportions seropositive against
rubella in Japan, comparing estimates before, during, and after the
epidemic and aiming to estimate the immunizing effect of the
epidemic. Three notable ﬁndings were obtained. First, while the
cases were mainly seen among men aged from 30-49 years old, no
signiﬁcant increase was observed in the proportion seropositive.
Second, for several male birth cohorts, the seroprevalence was well
below the herd immunity threshold level. Third, the age-
standardized proportion seropositive was calculated, and that
for males was as small as 76.7%. Not only men’s but also women’s
seroprevalence was below our reference value of the threshold.
All three ﬁndings warn that there are susceptible pockets left,
especially in unimmunized birth cohorts of adult men, which
accounted for 80% of cases during the epidemic 2012-14.
Susceptible cohorts could continue to fuel future rubella epidemics
in Japan. An important limitation of our study is that our deﬁnition
of seropositive (HI32) rested on a convention in Japan based on
small number of samples and the actual immune fraction could
potentially be greater than we calculated. Nevertheless, our
estimate is consistent with the occurrence of the major epidemic
from 2012-14, and moreover, our ﬁnding of the absence of increase
in seropositive fraction is seen with all other cut-off levelsincluding HI8 (results not shown). Limited herd immunity
levels among adult men are likely attributable to (i) missed chance
of vaccination and (ii) waning immunity. It must be noted that
males aged from 10-19 years followed the new protocol of
vaccination, but their seropositive fraction was below herd
immunity threshold, and moreover, the seroprevalence decreased
over three years, perhaps reﬂecting the loss of vaccine-induced
immunity. To ﬁll up the unvaccinated cohorts, the above
mentioned ﬁndings call for strong supplementary vaccination,
not only among women at child-bearing age, but also towards
previously unvaccinated men aged from 10s-40s. Otherwise, the
ﬁnding of the absence of increase in seroprevalence indicates that
Japan will continue to be prone to further epidemics. Moreover, if it
is certain that immunity in the substantial fraction of previously
vaccinated adults has been waned, it would be necessary to plan a
catch-up vaccination program. Continued monitoring of suscepti-
ble age groups by seroepidemiological survey would be essential,
as they permit estimating the epidemic size and designing the
most efﬁcient vaccination strategy.9,10
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